Quality of life and intrinsic capacity in patients with post-acute COVID-19 syndrome is in relation to frailty and resilience phenotypes.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
02 06 2023
02 06 2023
Historique:
received:
13
08
2022
accepted:
03
02
2023
medline:
5
6
2023
pubmed:
3
6
2023
entrez:
2
6
2023
Statut:
epublish
Résumé
The objective of this study was to characterize frailty and resilience in people evaluated for Post-Acute COVID-19 Syndrome (PACS), in relation to quality of life (QoL) and Intrinsic Capacity (IC). This cross-sectional, observational, study included consecutive people previously hospitalized for severe COVID-19 pneumonia attending Modena (Italy) PACS Clinic from July 2020 to April 2021. Four frailty-resilience phenotypes were built: "fit/resilient", "fit/non-resilient", "frail/resilient" and "frail/non-resilient". Frailty and resilience were defined according to frailty phenotype and Connor Davidson resilience scale (CD-RISC-25) respectively. Study outcomes were: QoL assessed by means of Symptoms Short form health survey (SF-36) and health-related quality of life (EQ-5D-5L) and IC by means of a dedicated questionnaire. Their predictors including frailty-resilience phenotypes were explored in logistic regressions. 232 patients were evaluated, median age was 58.0 years. PACS was diagnosed in 173 (74.6%) patients. Scarce resilience was documented in 114 (49.1%) and frailty in 72 (31.0%) individuals. Predictors for SF-36 score < 61.60 were the phenotypes "frail/non-resilient" (OR = 4.69, CI 2.08-10.55), "fit/non-resilient" (OR = 2.79, CI 1.00-7.73). Predictors for EQ-5D-5L < 89.7% were the phenotypes "frail/non-resilient" (OR = 5.93, CI 2.64-13.33) and "frail/resilient" (OR = 5.66, CI 1.93-16.54). Predictors of impaired IC (below the mean score value) were "frail/non-resilient" (OR = 7.39, CI 3.20-17.07), and "fit/non-resilient" (OR = 4.34, CI 2.16-8.71) phenotypes. Resilience and frailty phenotypes may have a different impact on wellness and QoL and may be evaluated in people with PACS to identify vulnerable individuals that require suitable interventions.
Identifiants
pubmed: 37268716
doi: 10.1038/s41598-023-29408-z
pii: 10.1038/s41598-023-29408-z
pmc: PMC10235830
doi:
Types de publication
Observational Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
8956Informations de copyright
© 2023. The Author(s).
Références
J Gerontol A Biol Sci Med Sci. 2018 Nov 10;73(12):1653-1660
pubmed: 29408961
Qual Life Res. 2016 May;25(5):1313-21
pubmed: 26482825
Ageing Res Rev. 2022 Nov;81:101686
pubmed: 35820609
Clin Microbiol Infect. 2021 Feb;27(2):258-263
pubmed: 33031948
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
BMJ. 2021 Mar 31;372:n693
pubmed: 33789877
Pharmacoeconomics. 2000 Jan;17(1):13-35
pubmed: 10747763
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
N Engl J Med. 2020 May 21;382(21):1973-1975
pubmed: 32202721
Clin Rev Allergy Immunol. 2023 Feb;64(1):66-74
pubmed: 33609255
J Am Geriatr Soc. 2018 Jul;66(7):1276-1283
pubmed: 29684237
Ann Intern Med. 2021 May;174(5):723-725
pubmed: 33284676
Depress Anxiety. 2003;18(2):76-82
pubmed: 12964174
J Nutr Health Aging. 2020;24(7):692-695
pubmed: 32744562
Lancet. 1999 Jan 16;353(9148):205-6
pubmed: 9923878
Int J Infect Dis. 2022 Dec;125:287-293
pubmed: 36191820
J Gerontol A Biol Sci Med Sci. 2016 Apr;71(4):489-95
pubmed: 26718984
BMC Med. 2020 Nov 10;18(1):355
pubmed: 33167965
Qual Life Res. 2021 Dec;30(12):3367-3381
pubmed: 34146226
J Med Virol. 2021 Apr;93(4):2453-2460
pubmed: 33377529
J Med Virol. 2021 Feb;93(2):1013-1022
pubmed: 32729939
Age Ageing. 2021 May 5;50(3):631-640
pubmed: 33951156
Int J Environ Res Public Health. 2021 Mar 05;18(5):
pubmed: 33807869
Thorax. 2021 Apr;76(4):396-398
pubmed: 33172844
Thorax. 2021 Apr;76(4):405-407
pubmed: 33273028
Arch Gerontol Geriatr. 2020 Jan - Feb;86:103939
pubmed: 31525556
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Transl Res. 2022 Mar;241:96-108
pubmed: 34695606
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
PLoS One. 2021 Aug 5;16(8):e0255427
pubmed: 34351975
PLoS Med. 2021 Sep 28;18(9):e1003773
pubmed: 34582441
J Am Med Dir Assoc. 2013 Jun;14(6):392-7
pubmed: 23764209
Respir Med. 2021 Jan;176:106272
pubmed: 33302142
Thorax. 2021 Apr;76(4):399-401
pubmed: 33273026